Predictors of Target Lesion In-stent Restenosis in Coronary Chronic Total Occlusion After Successful Percutaneous Recanalization: A Single-Center Experience with Clinically driven Follow-Up Angiography
This single-center study of 188 patients with successfully recanalized coronary chronic total occlusions identifies male gender, heart failure, high J-CTO scores, and bare-metal stent implantation as independent predictors of target lesion in-stent restenosis, highlighting a high recurrence rate even in the drug-eluting stent era.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart relies on a network of arteries to deliver oxygen-rich blood to its muscle, keeping the organ beating steadily. Sometimes, a blockage forms in one of these arteries, cutting off the flow. When a blockage is complete and has persisted for a long time, doctors call it a chronic total occlusion. For decades, fixing these stubborn, fully closed arteries was considered one of the most difficult tasks in heart medicine. However, with better tools and techniques, doctors can now often reopen these vessels using a minimally invasive procedure where a tiny tube is threaded through the blood vessels to the heart. Once the artery is opened, a small mesh tube called a stent is usually placed inside to hold the vessel open. While this procedure brings significant relief to patients, the body sometimes reacts by growing tissue over the stent, narrowing the artery again. This recurrence is known as in-stent restenosis, and it forces patients to undergo further testing and potentially more procedures. Understanding why this happens in some people but not others is crucial for improving long-term heart health.
A team of researchers at Taichung Veterans General Hospital and Feng Yuan Hospital in Taiwan set out to investigate exactly this problem. They focused on patients who had successfully undergone the procedure to reopen a chronically blocked artery and who later returned to the hospital because they developed new symptoms or showed signs of heart strain. These patients underwent a follow-up imaging test of their coronary arteries, which allowed the doctors to see clearly if the stent had become blocked again. The study looked at 188 such patients who were treated between 2015 and 2022. The researchers wanted to find out what specific factors made a patient more likely to experience this re-narrowing. They examined everything from the patient's medical history and blood test results to the specific type of stent used and the complexity of the original blockage.
The results revealed a surprisingly high rate of re-narrowing. Out of the 188 patients, 83, or about 44 percent, were found to have a blockage inside their stent during the follow-up imaging. This was a much higher number than what is typically seen in studies that only check patients on a fixed schedule, suggesting that when doctors wait for symptoms to appear, they often find that the artery has closed up again. The researchers discovered that the type of stent used was a major factor. Patients who received an older style of stent, known as a bare-metal stent, faced a significantly higher risk of re-narrowing compared to those who received a newer, drug-coated stent. In fact, among the patients with the older stents, nearly 69 percent experienced the artery closing up again. This finding strongly suggests that the older stents are not a suitable choice for these complex, long-term blockages.
Beyond the type of stent, the study identified several other independent factors that increased the risk of the artery closing up again. Men were more likely to experience re-narrowing than women. Patients who had a diagnosis of heart failure, a condition where the heart struggles to pump blood effectively, also faced higher risks. Additionally, the complexity of the original blockage mattered; doctors use a scoring system to rate how difficult a blockage is to open, and patients with higher scores were more likely to see the artery narrow again later. Interestingly, the researchers looked closely at the patients' blood chemistry, including their cholesterol levels, both before the initial procedure and at the time of the follow-up. They found that while cholesterol levels were slightly higher in the group that developed re-narrowing at the time of the first procedure, changes in these blood levels over time did not predict who would get a blockage. This indicates that the risk is driven more by the patient's physical characteristics and the nature of the procedure itself rather than by fluctuations in their blood chemistry during the recovery period.
When the researchers looked specifically at the patients who received the newer, drug-coated stents, the pattern remained similar. Men, patients with heart failure, and those with more complex blockages were still the most likely to experience re-narrowing. However, for the group that received the older bare-metal stents, the researchers could not identify any specific patient or procedure factors that predicted the outcome. This lack of a clear pattern, combined with the extremely high rate of failure in this group, reinforced the conclusion that the stent type itself was the overwhelming problem. The study highlights that even with successful initial surgery, the risk of the artery closing up again is substantial in the real world, particularly when older technology is used. The findings suggest that for patients with these difficult, long-standing blockages, the choice of stent and the patient's underlying heart condition are the primary drivers of success or failure, rather than the day-to-day management of blood test numbers.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.